Available for speaking
Matt Kaeberlein, PhD
CEO / Founder
Matt Kaeberlein, PhD is CEO / Founder. Areas of expertise include Rapamycin, aging biology, translational geroscience.
Biography
Prominent geroscientist known for rapamycin research and leadership in the Dog Aging Project.
